Health and health care; personal characteristics, 2014-2021
| Characteristics persons | Margins | Periods | Chronic disorders Disorders in the last 12 months Other disorders/diseases (%) | Acute diseases Cold (%) | Acute diseases Bronchitis or pneumonia (%) | Acute diseases Inflammation of the ear (%) | Acute diseases Inflammation kidneys or bladder (%) | Acute diseases Diarrhoea, at least 3 times in 24 hours (%) | Acute diseases Vomiting, at least 3 times in 24 hours (%) |
|---|---|---|---|---|---|---|---|---|---|
| Total | Value | 2014 | 10.3 | 38.4 | 1.5 | 3.4 | 3.0 | 10.1 | 3.8 |
| Total | Value | 2015 | 10.9 | 42.3 | 1.8 | 3.2 | 3.2 | 10.6 | 4.2 |
| Total | Value | 2016 | 10.8 | 41.3 | 2.0 | 3.5 | 2.9 | 10.8 | 4.4 |
| Total | Value | 2017 | 11.8 | 42.2 | 2.0 | 3.3 | 3.2 | 10.7 | 3.9 |
| Total | Value | 2018 | 12.3 | 41.3 | 2.0 | 3.3 | 2.9 | 12.3 | 4.2 |
| Total | Value | 2019 | 12.9 | . | . | . | . | . | . |
| Total | Value | 2020 | 13.0 | . | . | . | . | . | . |
| Total | Value | 2021 | 13.1 | 30.1 | 0.9 | 2.6 | 2.6 | 10.2 | 3.1 |
| Total | Lower bound 95% confidence interval | 2014 | 9.7 | 37.4 | 1.3 | 3.0 | 2.6 | 9.5 | 3.4 |
| Total | Lower bound 95% confidence interval | 2015 | 10.3 | 41.3 | 1.5 | 2.8 | 2.8 | 10.0 | 3.8 |
| Total | Lower bound 95% confidence interval | 2016 | 10.2 | 40.3 | 1.7 | 3.1 | 2.5 | 10.2 | 4.0 |
| Total | Lower bound 95% confidence interval | 2017 | 11.1 | 41.2 | 1.8 | 3.0 | 2.9 | 10.1 | 3.5 |
| Total | Lower bound 95% confidence interval | 2018 | 11.6 | 40.4 | 1.8 | 3.0 | 2.6 | 11.7 | 3.8 |
| Total | Lower bound 95% confidence interval | 2019 | 12.2 | . | . | . | . | . | . |
| Total | Lower bound 95% confidence interval | 2020 | 12.3 | . | . | . | . | . | . |
| Total | Lower bound 95% confidence interval | 2021 | 12.3 | 29.1 | 0.7 | 2.2 | 2.3 | 9.5 | 2.7 |
| Total | Upper bound 95% confidence interval | 2014 | 10.9 | 39.3 | 1.8 | 3.7 | 3.3 | 10.7 | 4.1 |
| Total | Upper bound 95% confidence interval | 2015 | 11.5 | 43.3 | 2.0 | 3.6 | 3.5 | 11.3 | 4.6 |
| Total | Upper bound 95% confidence interval | 2016 | 11.5 | 42.3 | 2.3 | 3.8 | 3.2 | 11.5 | 4.8 |
| Total | Upper bound 95% confidence interval | 2017 | 12.4 | 43.1 | 2.3 | 3.7 | 3.5 | 11.3 | 4.2 |
| Total | Upper bound 95% confidence interval | 2018 | 12.9 | 42.3 | 2.3 | 3.7 | 3.2 | 13.0 | 4.6 |
| Total | Upper bound 95% confidence interval | 2019 | 13.5 | . | . | . | . | . | . |
| Total | Upper bound 95% confidence interval | 2020 | 13.7 | . | . | . | . | . | . |
| Total | Upper bound 95% confidence interval | 2021 | 13.9 | 31.2 | 1.2 | 3.0 | 3.0 | 10.9 | 3.6 |
| Sex: Male | Value | 2014 | 9.0 | 37.1 | 1.3 | 3.1 | 1.3 | 8.9 | 2.6 |
| Sex: Male | Value | 2015 | 9.3 | 40.8 | 1.7 | 2.8 | 1.3 | 10.2 | 3.1 |
| Sex: Male | Value | 2016 | 9.1 | 41.1 | 1.8 | 3.1 | 1.3 | 10.3 | 3.6 |
| Sex: Male | Value | 2017 | 10.8 | 40.6 | 1.9 | 3.1 | 1.1 | 9.6 | 3.1 |
| Sex: Male | Value | 2018 | 10.5 | 40.6 | 1.8 | 3.0 | 1.3 | 11.1 | 3.8 |
| Sex: Male | Value | 2019 | 11.2 | . | . | . | . | . | . |
| Sex: Male | Value | 2020 | 10.8 | . | . | . | . | . | . |
| Sex: Male | Value | 2021 | 11.2 | 30.1 | 0.9 | 2.6 | 1.5 | 9.2 | 2.0 |
| Sex: Male | Lower bound 95% confidence interval | 2014 | 8.2 | 35.7 | 1.0 | 2.6 | 1.0 | 8.1 | 2.1 |
| Sex: Male | Lower bound 95% confidence interval | 2015 | 8.5 | 39.3 | 1.3 | 2.3 | 1.0 | 9.3 | 2.6 |
| Sex: Male | Lower bound 95% confidence interval | 2016 | 8.3 | 39.7 | 1.4 | 2.6 | 0.9 | 9.4 | 3.1 |
| Sex: Male | Lower bound 95% confidence interval | 2017 | 9.9 | 39.2 | 1.5 | 2.6 | 0.8 | 8.7 | 2.6 |
| Sex: Male | Lower bound 95% confidence interval | 2018 | 9.6 | 39.2 | 1.4 | 2.5 | 1.0 | 10.2 | 3.3 |
| Sex: Male | Lower bound 95% confidence interval | 2019 | 10.3 | . | . | . | . | . | . |
| Sex: Male | Lower bound 95% confidence interval | 2020 | 9.9 | . | . | . | . | . | . |
| Sex: Male | Lower bound 95% confidence interval | 2021 | 10.3 | 28.6 | 0.7 | 2.1 | 1.1 | 8.3 | 1.6 |
| Sex: Male | Upper bound 95% confidence interval | 2014 | 9.8 | 38.4 | 1.6 | 3.6 | 1.6 | 9.8 | 3.1 |
| Sex: Male | Upper bound 95% confidence interval | 2015 | 10.2 | 42.2 | 2.1 | 3.2 | 1.6 | 11.0 | 3.6 |
| Sex: Male | Upper bound 95% confidence interval | 2016 | 9.9 | 42.6 | 2.2 | 3.6 | 1.6 | 11.2 | 4.2 |
| Sex: Male | Upper bound 95% confidence interval | 2017 | 11.7 | 42.0 | 2.3 | 3.6 | 1.4 | 10.4 | 3.6 |
| Sex: Male | Upper bound 95% confidence interval | 2018 | 11.3 | 41.9 | 2.1 | 3.5 | 1.6 | 11.9 | 4.4 |
| Sex: Male | Upper bound 95% confidence interval | 2019 | 12.0 | . | . | . | . | . | . |
| Sex: Male | Upper bound 95% confidence interval | 2020 | 11.8 | . | . | . | . | . | . |
| Sex: Male | Upper bound 95% confidence interval | 2021 | 12.3 | 31.6 | 1.3 | 3.1 | 1.9 | 10.2 | 2.6 |
| Sex: Female | Value | 2014 | 11.7 | 39.6 | 1.8 | 3.6 | 4.6 | 11.3 | 4.9 |
| Sex: Female | Value | 2015 | 12.5 | 43.8 | 1.8 | 3.6 | 5.0 | 11.1 | 5.3 |
| Sex: Female | Value | 2016 | 12.5 | 41.5 | 2.2 | 3.8 | 4.5 | 11.3 | 5.2 |
| Sex: Female | Value | 2017 | 12.7 | 43.7 | 2.2 | 3.5 | 5.2 | 11.8 | 4.6 |
| Sex: Female | Value | 2018 | 14.0 | 42.1 | 2.3 | 3.7 | 4.4 | 13.6 | 4.6 |
| Sex: Female | Value | 2019 | 14.6 | . | . | . | . | . | . |
| Sex: Female | Value | 2020 | 15.2 | . | . | . | . | . | . |
| Sex: Female | Value | 2021 | 14.9 | 30.2 | 0.9 | 2.6 | 3.7 | 11.2 | 4.2 |
| Sex: Female | Lower bound 95% confidence interval | 2014 | 10.7 | 38.2 | 1.4 | 3.1 | 4.0 | 10.4 | 4.3 |
| Sex: Female | Lower bound 95% confidence interval | 2015 | 11.5 | 42.4 | 1.4 | 3.1 | 4.4 | 10.2 | 4.7 |
| Sex: Female | Lower bound 95% confidence interval | 2016 | 11.6 | 40.1 | 1.7 | 3.2 | 3.9 | 10.4 | 4.6 |
| Sex: Female | Lower bound 95% confidence interval | 2017 | 11.8 | 42.3 | 1.8 | 3.0 | 4.6 | 10.9 | 4.0 |
| Sex: Female | Lower bound 95% confidence interval | 2018 | 13.1 | 40.7 | 1.9 | 3.2 | 3.9 | 12.6 | 4.0 |
| Sex: Female | Lower bound 95% confidence interval | 2019 | 13.6 | . | . | . | . | . | . |
| Sex: Female | Lower bound 95% confidence interval | 2020 | 14.1 | . | . | . | . | . | . |
| Sex: Female | Lower bound 95% confidence interval | 2021 | 13.8 | 28.7 | 0.6 | 2.1 | 3.1 | 10.2 | 3.6 |
| Sex: Female | Upper bound 95% confidence interval | 2014 | 12.6 | 41.0 | 2.1 | 4.1 | 5.2 | 12.2 | 5.5 |
| Sex: Female | Upper bound 95% confidence interval | 2015 | 13.4 | 45.2 | 2.2 | 4.2 | 5.6 | 12.0 | 6.0 |
| Sex: Female | Upper bound 95% confidence interval | 2016 | 13.5 | 42.9 | 2.6 | 4.3 | 5.1 | 12.2 | 5.8 |
| Sex: Female | Upper bound 95% confidence interval | 2017 | 13.6 | 45.1 | 2.6 | 4.1 | 5.8 | 12.7 | 5.2 |
| Sex: Female | Upper bound 95% confidence interval | 2018 | 15.0 | 43.4 | 2.7 | 4.2 | 5.0 | 14.5 | 5.2 |
| Sex: Female | Upper bound 95% confidence interval | 2019 | 15.6 | . | . | . | . | . | . |
| Sex: Female | Upper bound 95% confidence interval | 2020 | 16.2 | . | . | . | . | . | . |
| Sex: Female | Upper bound 95% confidence interval | 2021 | 16.1 | 31.7 | 1.3 | 3.2 | 4.4 | 12.3 | 4.9 |
| Age: 0 to 3 years | Value | 2014 | 3.1 | 68.5 | 2.0 | 12.4 | 1.3 | 16.0 | 9.2 |
| Age: 0 to 3 years | Value | 2015 | 4.0 | 72.9 | 0.9 | 10.8 | 1.4 | 15.6 | 9.0 |
| Age: 0 to 3 years | Value | 2016 | 4.6 | 74.2 | 2.3 | 10.0 | 1.0 | 18.8 | 11.1 |
| Age: 0 to 3 years | Value | 2017 | 4.2 | 71.3 | 3.9 | 11.9 | 0.5 | 16.3 | 11.0 |
| Age: 0 to 3 years | Value | 2018 | 5.8 | 66.3 | 2.3 | 12.8 | 0.3 | 21.5 | 11.9 |
| Age: 0 to 3 years | Value | 2019 | 9.4 | . | . | . | . | . | . |
| Age: 0 to 3 years | Value | 2020 | 6.9 | . | . | . | . | . | . |
| Age: 0 to 3 years | Value | 2021 | 5.9 | 65.5 | 1.7 | 6.8 | 0.8 | 15.3 | 11.9 |
| Age: 0 to 3 years | Lower bound 95% confidence interval | 2014 | 1.4 | 64.0 | 0.6 | 9.2 | 0.2 | 12.4 | 6.4 |
| Age: 0 to 3 years | Lower bound 95% confidence interval | 2015 | 2.0 | 68.5 | 0.0 | 7.8 | 0.3 | 12.0 | 6.2 |
| Age: 0 to 3 years | Lower bound 95% confidence interval | 2016 | 2.5 | 69.8 | 0.8 | 7.0 | 0.0 | 14.8 | 7.9 |
| Age: 0 to 3 years | Lower bound 95% confidence interval | 2017 | 2.2 | 66.9 | 2.0 | 8.7 | 0.0 | 12.7 | 7.9 |
| Age: 0 to 3 years | Lower bound 95% confidence interval | 2018 | 3.5 | 61.7 | 0.8 | 9.6 | 0.0 | 17.5 | 8.7 |
| Age: 0 to 3 years | Lower bound 95% confidence interval | 2019 | 6.5 | . | . | . | . | . | . |
| Age: 0 to 3 years | Lower bound 95% confidence interval | 2020 | 4.2 | . | . | . | . | . | . |
| Age: 0 to 3 years | Lower bound 95% confidence interval | 2021 | 3.8 | 60.0 | 0.7 | 4.5 | 0.2 | 11.6 | 8.6 |
| Age: 0 to 3 years | Upper bound 95% confidence interval | 2014 | 4.8 | 73.0 | 3.3 | 15.6 | 2.5 | 19.5 | 12.0 |
| Age: 0 to 3 years | Upper bound 95% confidence interval | 2015 | 5.9 | 77.3 | 1.8 | 13.9 | 2.6 | 19.2 | 11.8 |
| Age: 0 to 3 years | Upper bound 95% confidence interval | 2016 | 6.7 | 78.6 | 3.8 | 13.0 | 2.0 | 22.7 | 14.2 |
| Age: 0 to 3 years | Upper bound 95% confidence interval | 2017 | 6.1 | 75.7 | 5.8 | 15.1 | 1.1 | 19.9 | 14.0 |
| Age: 0 to 3 years | Upper bound 95% confidence interval | 2018 | 8.0 | 70.9 | 3.7 | 16.0 | 0.9 | 25.5 | 15.0 |
| Age: 0 to 3 years | Upper bound 95% confidence interval | 2019 | 12.3 | . | . | . | . | . | . |
| Age: 0 to 3 years | Upper bound 95% confidence interval | 2020 | 9.6 | . | . | . | . | . | . |
| Age: 0 to 3 years | Upper bound 95% confidence interval | 2021 | 9.1 | 70.6 | 3.7 | 10.1 | 3.0 | 19.9 | 16.1 |
| Age: 4 to 11 years | Value | 2014 | 5.4 | 43.2 | 1.1 | 8.0 | 0.8 | 7.7 | 5.7 |
| Age: 4 to 11 years | Value | 2015 | 4.8 | 49.7 | 0.6 | 7.0 | 1.1 | 10.1 | 6.0 |
| Age: 4 to 11 years | Value | 2016 | 6.5 | 52.2 | 0.6 | 7.2 | 0.8 | 8.8 | 7.1 |
| Age: 4 to 11 years | Value | 2017 | 6.2 | 52.3 | 1.5 | 6.8 | 1.2 | 9.0 | 6.1 |
| Source: CBS. | |||||||||
Dataset is not available.
This table contains data on the perceived state of health and on contacts with providers of medical care of the Dutch population in private households. These data can be grouped by several personal characteristics.
Data available for 2014-2021
Status of the data: final.
Changes as of July 31, 2023:
None, the table has been discontinued.
When will new data be published?
Not applicable. This table has been replaced, see paragraph 3 for a link to the new table.
Description topics
- Chronic disorders
- All respondents are asked: ꞌDo you /Does your child have one or more chronic disorders?ꞌ Chronic means (in anticipation) 6 months or longer. Next, 23 disorders and a remainder category 'other disorders' are presented and persons are asked if they had this disorder during the last 12 months. Persons are asked after 3 of these disorders if they ever suffered from it. Besides (more elaborately) is asked after diabetes. Most questions on specific chronic disorders are being asked to persons of all ages. Questions on disorders that do not occur amongst youngsters are posed to persons of 12 years or older.
- Disorders in the last 12 months
- Chronic diseases/disorders in the last 12 months. Respondents may currently suffer from the disease/disorder or have suffered from it in the last 12 months.
- Other disorders/diseases
- Percentage of persons who answered ꞌyesꞌ to the question: ꞌHave you / Has your child suffered from another chronic disease or disorder in the last 12 months, not mentioned before?'
- Acute diseases
- Questions are asked on 6 acute diseases or complaints. With the answer ꞌyesꞌ or ꞌnoꞌ the respondent can indicate if he had the complaints during the last 2 months. The questions are asked to respondents of all ages.In 2019 and 2020, questions about acute illnesses or complaints were not included in the survey.
- Cold
- Percentage of persons who answered ꞌyesꞌ to the question: ꞌHave you / Has your child suffered from a cold, influenza, an inflammation of the throat or sinusitis during the last 2 months?'
- Bronchitis or pneumonia
- Percentage of persons who answered ꞌyesꞌ to the question: ꞌHave you / Has your child suffered from bronchitis or pneumonia during the last 2 months, (excluding. chronic bronchitis)?'
- Inflammation of the ear
- Percentage of persons who answered ꞌyesꞌ to the question: ꞌHave you / Has your child suffered from an inflammation of the ear during the last 2 months?'
- Inflammation kidneys or bladder
- Percentage of persons who answered ꞌyesꞌ to the question: ꞌHave you / Has your child suffered from an infection or inflammation of the kidneys, bladder or urinary tract during the last 2 months?'
- Diarrhoea, at least 3 times in 24 hours
- Percentage of persons who answered ꞌyesꞌ to the question: ꞌHave you / Has your child suffered from diarrhoea during the last 2 months (liquid faeces at least 3 times within 24 hours)?'
- Vomiting, at least 3 times in 24 hours
- Vomiting, at least 3 times in 24 hours